Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Celecoxib Inhibits Cdx2 Expression and Prevents Gastric Cancer in <i>Helicobacter pylori</i>-Infected Mongolian Gerbils

View through CrossRef
<i>Background/Aim:</i> The aim of this study was to see whether administration of celecoxib, a selective COX-2 inhibitor, prior to the appearance of intestinal metaplasia could prevent the development of gastric cancer in <i>Helicobacter pylori</i>-infected Mongolian gerbils. <i>Methods:</i>Fifty-two Mongolian gerbilswere divided into 3 groups and given 5 biweekly doses of N-methyl-N-nitrosourea (MNU; 30 ppm). At week 12, group 2 (n = 20) and group 3 (n = 22) gerbils were then given an injection of <i>H. pylori</i>, while group 1 controls (n = 10) received<i> Brucella</i> broth alone. In addition, 7 weeks after <i>H. pylori </i>inoculation, at week 19, group 3 gerbils also received a 36-week administration course of celecoxib (1,500 ppm) in their diet. The incidence of gastric adenocarcinoma was determined at week 54 by histological analysis. COX-2 and Cdx2 protein expression and COX activity were evaluated for each group. The extent of intestinal metaplasia, Cdx2 and MUC2 expression, and the apoptotic index were evaluated semi-quantitatively by immunohistochemistry. <i>Results:</i> The incidence of gastric adenocarcinoma was: group 1, 0% (0/10); group 2, 65% (13/20), and group 3, 23% (5/22; p < 0.05). Continuous celecoxib administration significantly reduced COX activity and COX-2 protein expression, Cdx2 and MUC2 protein immunoreactivity, and the extent of Alcian blue periodic acid-Schiff-positive intestinal metaplasia in <i>H. pylori</i>-infected gerbils. Celecoxib also induced apoptosis in these gerbils. Significant inhibition of Cdx2 expression in group 3 gerbils was also shown by Western blot analysis. <i>Conclusions:</i> Prior to the first appearance of intestinal metaplasia, timely administration of celecoxib prevents gastric cancer occurrence by disrupting the progression of intestinal metaplasia into gastric carcinoma through its inhibition of Cdx2 expression in MNU-pretreated <i>H. pylori</i>-infected Mongolian gerbils.
Title: Celecoxib Inhibits Cdx2 Expression and Prevents Gastric Cancer in <i>Helicobacter pylori</i>-Infected Mongolian Gerbils
Description:
<i>Background/Aim:</i> The aim of this study was to see whether administration of celecoxib, a selective COX-2 inhibitor, prior to the appearance of intestinal metaplasia could prevent the development of gastric cancer in <i>Helicobacter pylori</i>-infected Mongolian gerbils.
<i>Methods:</i>Fifty-two Mongolian gerbilswere divided into 3 groups and given 5 biweekly doses of N-methyl-N-nitrosourea (MNU; 30 ppm).
At week 12, group 2 (n = 20) and group 3 (n = 22) gerbils were then given an injection of <i>H.
pylori</i>, while group 1 controls (n = 10) received<i> Brucella</i> broth alone.
In addition, 7 weeks after <i>H.
pylori </i>inoculation, at week 19, group 3 gerbils also received a 36-week administration course of celecoxib (1,500 ppm) in their diet.
The incidence of gastric adenocarcinoma was determined at week 54 by histological analysis.
COX-2 and Cdx2 protein expression and COX activity were evaluated for each group.
The extent of intestinal metaplasia, Cdx2 and MUC2 expression, and the apoptotic index were evaluated semi-quantitatively by immunohistochemistry.
<i>Results:</i> The incidence of gastric adenocarcinoma was: group 1, 0% (0/10); group 2, 65% (13/20), and group 3, 23% (5/22; p < 0.
05).
Continuous celecoxib administration significantly reduced COX activity and COX-2 protein expression, Cdx2 and MUC2 protein immunoreactivity, and the extent of Alcian blue periodic acid-Schiff-positive intestinal metaplasia in <i>H.
pylori</i>-infected gerbils.
Celecoxib also induced apoptosis in these gerbils.
Significant inhibition of Cdx2 expression in group 3 gerbils was also shown by Western blot analysis.
<i>Conclusions:</i> Prior to the first appearance of intestinal metaplasia, timely administration of celecoxib prevents gastric cancer occurrence by disrupting the progression of intestinal metaplasia into gastric carcinoma through its inhibition of Cdx2 expression in MNU-pretreated <i>H.
pylori</i>-infected Mongolian gerbils.

Related Results

Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo
Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo
Helicobacter pylori transactivates the Epidermal Growth Factor Receptor (EGFR) and predisposes to gastric cancer development in humans and animal models. To examine the importance ...
Differential E-cadherin expression in helicobacter-related gastric pathology
Differential E-cadherin expression in helicobacter-related gastric pathology
Background and aims E-cadherin plays an important role in the maintenance of cell–cell adhesion. Loss of E-cadherin expression is fundamental in the development of many...
Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis
Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis
Infection with Helicobacter pylori is associated with the development of gastric cancer. Although the prevalence of gastric cancer has declined throughout years due to improvement ...
Role of Helicobacter pylori Infection and Host Genetic Polymorphisms in Gastric Cancer Susceptibility: A Systematic Review
Role of Helicobacter pylori Infection and Host Genetic Polymorphisms in Gastric Cancer Susceptibility: A Systematic Review
Background Despite ongoing efforts, gastric cancer remains a leading cause of cancer-related death worldwide, with its high risk primarily attributed to Helicobacter pylori (H. py...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...

Back to Top